|
Maternal mediators of fetal growth restriction linked to prenatal alcohol exposure |
1R01AA029594-01A1 |
|
NIAAA |
2022 |
|
Cardiovascular disease in fetal alcohol spectrum disorder |
1U01AA030185-01 |
|
NIAAA |
2022 |
|
Project 2: Prenatal Alcohol Exposure (PAE) and Fetal Alcohol Spectrum Disorder (FASD) |
1U54AA030451-01 |
|
NIAAA |
2022 |
|
Prenatal Alcohol Exposure and Fetal Alcohol Spectrum Disorder |
1U54AA030463-01 |
|
NIAAA |
2022 |
|
Prenatal Alcohol and Neuroimmunity |
5R01AA022460-08 |
|
NIAAA |
2022 |
|
Fetal alcohol exposure: effects on immunity of the premature newborn |
5R01AA027020-04 |
|
NIAAA |
2022 |
|
Role of TNFalpha in discogenic pain progression and as a treatment target |
1R01AR078857-01A1 |
|
NIAMS |
2022 |
|
Interdependency of fibroadipogenic progenitors and extracellular matrix that drive skeletal muscle fibrosis |
1R01AR079545-01A1 |
|
NIAMS |
2022 |
|
Is the gut important in multiple joint osteoarthritis? A multimodal investigation in humans and pet dogs |
1R01AR080733-01 |
|
NIAMS |
2022 |
|
Allele Specific Knockdown for LGMD-D1 |
1R03AR081395-01 |
|
NIAMS |
2022 |